financetom
Business
financetom
/
Business
/
BRIEF-Genmab To Buy Merus For USD 8.0 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Genmab To Buy Merus For USD 8.0 Billion
Sep 28, 2025 10:37 PM

Sept 29 (Reuters) - Genmab A/S ( GMAB ):

* GENMAB TO ACQUIRE MERUS, EXPANDING LATE-STAGE PIPELINE AND

ACCELERATING INTO A WHOLLY OWNED MODEL

* GENMAB A/S ( GMAB ) - TO BUY MERUS FOR USD 8.0 BILLION

* GENMAB A/S ( GMAB ) - DEAL EXPECTED TO BE ACCRETIVE TO EBITDA BY

2029

* GENMAB A/S ( GMAB ) - USD 97.00 PER SHARE REPRESENTS 41% PREMIUM

OVER

CLOSING PRICE

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Argentina set for M&A boom under Milei, with energy in focus, PwC says
Argentina set for M&A boom under Milei, with energy in focus, PwC says
Jun 9, 2025
BUENOS AIRES, June 9 (Reuters) - Argentina's mergers and acquisitions market could grow significantly in the coming years if President Javier Milei's economic reforms continue, Juan Tripier, director of M&A and corporate finance at PricewaterhouseCoopers (PwC) Argentina, told Reuters. Investors have shown renewed interest in Argentina following Milei's measures, which include sharp reductions in inflation and public spending, a restored...
Sixth Street-backed Caris Life Sciences targets $5.3 billion valuation in US IPO
Sixth Street-backed Caris Life Sciences targets $5.3 billion valuation in US IPO
Jun 9, 2025
(Reuters) -Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in its initial public offering in the United States. Irving, Texas-based Caris plans to raise up to $424 million by offering 23.5 million shares priced between $16 and $18 apiece. The IPO market is heating up as high-profile companies move...
Sixth Street-backed Caris Life Sciences targets $5.3 billion valuation in US IPO
Sixth Street-backed Caris Life Sciences targets $5.3 billion valuation in US IPO
Jun 9, 2025
June 9 (Reuters) - Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in its initial public offering in the United States. Irving, Texas-based Caris plans to raise up to $424 million by offering 23.5 million shares priced between $16 and $18 apiece. The IPO market is heating up as...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved